Cargando…
Genome-Wide Analysis of Left Ventricular Maximum Wall Thickness in the UK Biobank Cohort Reveals a Shared Genetic Background With Hypertrophic Cardiomyopathy
Left ventricular maximum wall thickness (LVMWT) is an important biomarker of left ventricular hypertrophy and provides diagnostic and prognostic information in hypertrophic cardiomyopathy (HCM). Limited information is available on the genetic determinants of LVMWT. METHODS: We performed a genome-wid...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946169/ https://www.ncbi.nlm.nih.gov/pubmed/36598836 http://dx.doi.org/10.1161/CIRCGEN.122.003716 |
_version_ | 1784892278260629504 |
---|---|
author | Aung, Nay Lopes, Luis R. van Duijvenboden, Stefan Harper, Andrew R. Goel, Anuj Grace, Christopher Ho, Carolyn Y. Weintraub, William S. Kramer, Christopher M. Neubauer, Stefan Watkins, Hugh C. Petersen, Steffen E. Munroe, Patricia B. |
author_facet | Aung, Nay Lopes, Luis R. van Duijvenboden, Stefan Harper, Andrew R. Goel, Anuj Grace, Christopher Ho, Carolyn Y. Weintraub, William S. Kramer, Christopher M. Neubauer, Stefan Watkins, Hugh C. Petersen, Steffen E. Munroe, Patricia B. |
author_sort | Aung, Nay |
collection | PubMed |
description | Left ventricular maximum wall thickness (LVMWT) is an important biomarker of left ventricular hypertrophy and provides diagnostic and prognostic information in hypertrophic cardiomyopathy (HCM). Limited information is available on the genetic determinants of LVMWT. METHODS: We performed a genome-wide association study of LVMWT measured from the cardiovascular magnetic resonance examinations of 42 176 European individuals. We evaluated the genetic relationship between LVMWT and HCM by performing pairwise analysis using the data from the Hypertrophic Cardiomyopathy Registry in which the controls were randomly selected from UK Biobank individuals not included in the cardiovascular magnetic resonance sub-study. RESULTS: Twenty-one genetic loci were discovered at P<5×10(−8). Several novel candidate genes were identified including PROX1, PXN, and PTK2, with known functional roles in myocardial growth and sarcomere organization. The LVMWT genetic risk score is predictive of HCM in the Hypertrophic Cardiomyopathy Registry (odds ratio per SD: 1.18 [95% CI, 1.13–1.23]) with pairwise analyses demonstrating a moderate genetic correlation (r(g)=0.53) and substantial loci overlap (19/21). CONCLUSIONS: Our findings provide novel insights into the genetic underpinning of LVMWT and highlight its shared genetic background with HCM, supporting future endeavours to elucidate the genetic etiology of HCM. |
format | Online Article Text |
id | pubmed-9946169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-99461692023-02-23 Genome-Wide Analysis of Left Ventricular Maximum Wall Thickness in the UK Biobank Cohort Reveals a Shared Genetic Background With Hypertrophic Cardiomyopathy Aung, Nay Lopes, Luis R. van Duijvenboden, Stefan Harper, Andrew R. Goel, Anuj Grace, Christopher Ho, Carolyn Y. Weintraub, William S. Kramer, Christopher M. Neubauer, Stefan Watkins, Hugh C. Petersen, Steffen E. Munroe, Patricia B. Circ Genom Precis Med Original Articles Left ventricular maximum wall thickness (LVMWT) is an important biomarker of left ventricular hypertrophy and provides diagnostic and prognostic information in hypertrophic cardiomyopathy (HCM). Limited information is available on the genetic determinants of LVMWT. METHODS: We performed a genome-wide association study of LVMWT measured from the cardiovascular magnetic resonance examinations of 42 176 European individuals. We evaluated the genetic relationship between LVMWT and HCM by performing pairwise analysis using the data from the Hypertrophic Cardiomyopathy Registry in which the controls were randomly selected from UK Biobank individuals not included in the cardiovascular magnetic resonance sub-study. RESULTS: Twenty-one genetic loci were discovered at P<5×10(−8). Several novel candidate genes were identified including PROX1, PXN, and PTK2, with known functional roles in myocardial growth and sarcomere organization. The LVMWT genetic risk score is predictive of HCM in the Hypertrophic Cardiomyopathy Registry (odds ratio per SD: 1.18 [95% CI, 1.13–1.23]) with pairwise analyses demonstrating a moderate genetic correlation (r(g)=0.53) and substantial loci overlap (19/21). CONCLUSIONS: Our findings provide novel insights into the genetic underpinning of LVMWT and highlight its shared genetic background with HCM, supporting future endeavours to elucidate the genetic etiology of HCM. Lippincott Williams & Wilkins 2023-01-04 /pmc/articles/PMC9946169/ /pubmed/36598836 http://dx.doi.org/10.1161/CIRCGEN.122.003716 Text en © 2022 The Authors. https://creativecommons.org/licenses/by/4.0/Circulation: Genomic and Precision Medicine is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited. |
spellingShingle | Original Articles Aung, Nay Lopes, Luis R. van Duijvenboden, Stefan Harper, Andrew R. Goel, Anuj Grace, Christopher Ho, Carolyn Y. Weintraub, William S. Kramer, Christopher M. Neubauer, Stefan Watkins, Hugh C. Petersen, Steffen E. Munroe, Patricia B. Genome-Wide Analysis of Left Ventricular Maximum Wall Thickness in the UK Biobank Cohort Reveals a Shared Genetic Background With Hypertrophic Cardiomyopathy |
title | Genome-Wide Analysis of Left Ventricular Maximum Wall Thickness in the UK Biobank Cohort Reveals a Shared Genetic Background With Hypertrophic Cardiomyopathy |
title_full | Genome-Wide Analysis of Left Ventricular Maximum Wall Thickness in the UK Biobank Cohort Reveals a Shared Genetic Background With Hypertrophic Cardiomyopathy |
title_fullStr | Genome-Wide Analysis of Left Ventricular Maximum Wall Thickness in the UK Biobank Cohort Reveals a Shared Genetic Background With Hypertrophic Cardiomyopathy |
title_full_unstemmed | Genome-Wide Analysis of Left Ventricular Maximum Wall Thickness in the UK Biobank Cohort Reveals a Shared Genetic Background With Hypertrophic Cardiomyopathy |
title_short | Genome-Wide Analysis of Left Ventricular Maximum Wall Thickness in the UK Biobank Cohort Reveals a Shared Genetic Background With Hypertrophic Cardiomyopathy |
title_sort | genome-wide analysis of left ventricular maximum wall thickness in the uk biobank cohort reveals a shared genetic background with hypertrophic cardiomyopathy |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946169/ https://www.ncbi.nlm.nih.gov/pubmed/36598836 http://dx.doi.org/10.1161/CIRCGEN.122.003716 |
work_keys_str_mv | AT aungnay genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy AT lopesluisr genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy AT vanduijvenbodenstefan genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy AT harperandrewr genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy AT goelanuj genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy AT gracechristopher genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy AT hocarolyny genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy AT weintraubwilliams genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy AT kramerchristopherm genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy AT neubauerstefan genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy AT watkinshughc genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy AT petersensteffene genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy AT munroepatriciab genomewideanalysisofleftventricularmaximumwallthicknessintheukbiobankcohortrevealsasharedgeneticbackgroundwithhypertrophiccardiomyopathy |